The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: A systematic review

European Urology

Volumn 65, Issue 5, 2014, Pages 918-927

  Yuh, Bertram ^a   Artibani, Walter ^b   Heidenreich, Axel ^c   Kimm, Simon ^d   Menon, Mani ^e   Novara, Giacomo ^f   Tewari, Ashutosh ^g   Touijer, Karim ^d   Wilson, Timothy ^a   Zorn, Kevin C ^h   Eggener, Scott E ⁱ  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e HENRY FORD HOSPITAL   (United States)

^f UNIVERSITY OF PADOVA   (Italy)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

High risk; Lymph node dissection; Prostate cancer; Prostatectomy; Robotic

Indexed keywords

BIOCHEMICAL RECURRENCE FREE SURVIVAL; BIOPSY; CATHETERIZATION; FOLLOW UP; GLEASON SCORE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LYMPH NODE DISSECTION; LYMPHOCELE; MEDLINE; MICTURITION; OPERATION DURATION; OPERATIVE BLOOD LOSS; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; ROBOTICS; SEXUAL FUNCTION; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

HIGH RISK; LYMPH NODE DISSECTION; PROSTATE CANCER; PROSTATECTOMY; ROBOTIC;

DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHOCELE; MALE; PATIENT SELECTION; PELVIS; PERIPHERAL NERVE INJURIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROBOTICS; URINARY INCONTINENCE;

EID: 84896398127     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.05.026     Document Type: Review

References (50)

1. M.M. Center, A. Jemal, and J. Lortet-Tieulent et al. International variation in prostate cancer incidence and mortality rates Eur Urol 61 2012 1079 1092
2. Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR. CaPSURE. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE) [published correction appears in J Urol 2004;171:811]. J Urol 2003;170:S21-5; discussion S26-7.
3. J.R. Rider, F. Sandin, O. Andrén, P. Wiklund, J. Hugosson, and P. Stattin Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study Eur Urol 63 2013 88 96
4. O. Yossepowitch, S.E. Eggener, and A.M. Serio et al. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy Eur Urol 53 2008 950 959
5. A.V. D'Amico, R. Whittington, and S.B. Malkowicz et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
6. A.B. Jani, P.A. Johnstone, S.L. Liauw, V.A. Master, and O.W. Brawley Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis Am J Clin Oncol 31 2008 375 378
7. O. Yossepowitch, and J.A. Eastham Radical prostatectomy for high-risk prostate cancer World J Urol 26 2008 219 224
8. F. Abdollah, M. Sun, and J. Schmitges et al. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics J Urol 188 2012 73 83
9. G. Ploussard, A. Masson-Lecomte, and J.B. Beauval et al. Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification Urology 78 2011 607 613
10. A. Briganti, S. Joniau, and P. Gontero et al. Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer Eur Urol 61 2012 584 592
11. S. Yamamoto, S. Kawakami, and J. Yonese et al. Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy Jpn J Clin Oncol 42 2012 541 547
12. A. Heidenreich, J. Bellmunt, and M. Bolla et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61 71
13. G. Novara, V. Ficarra, and R.C. Rosen et al. Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy Eur Urol 62 2012 431 452
14. V. Ficarra, G. Novara, and T.E. Ahlering et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy Eur Urol 62 2012 418 430
15. R.C. Martin II, M.F. Brennan, and D.P. Jaques Quality of complication reporting in the surgical literature Ann Surg 235 2002 803 813
16. J.P. Mulhall Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions J Urol 181 2009 462 471
17. OCEBM levels of evidence system. Oxford Centre for Evidence-Based Medicine Web site. http://www.cebm.net/index.aspx?o=5653.
18. S.A. Shikanov, A. Thong, and O.N. Gofrit et al. Robotic laparoscopic radical prostatectomy for biopsy Gleason 8 to 10: prediction of favorable pathologic outcome with preoperative parameters J Endourol 22 2008 1477 1481
19. W.S. Ham, S.Y. Park, K.H. Rha, W.T. Kim, and Y.D. Choi Robotic radical prostatectomy for patients with locally advanced prostate cancer is feasible: results of a single-institution study J Laparoendosc Adv Surg Tech A 19 2009 329 332
20. V. Zugor, J.H. Witt, A. Heidenreich, D. Porres, and A.P. Labanaris Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy Anticancer Res 32 2012 2091 2095
21. S.S. Connolly, P.J. Cathcart, and P. Gilmore et al. Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localised prostate cancer: initial experience of 160 men BJU Int 109 2012 752 759
22. D.S. Yee, N. Narula, M.B. Amin, D.W. Skarecky, and T.E. Ahlering Robot-assisted radical prostatectomy: current evaluation of surgical margins in clinically low-, intermediate-, and high-risk prostate cancer J Endourol 23 2009 1461 1465
23. H.J. Lavery, F. Nabizada-Pace, J.R. Carlucci, J.S. Brajtbord, and D.B. Samadi Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious Urol Oncol 30 2012 26 32
24. C.G. Rogers, J.D. Sammon, S. Sukumar, M. Diaz, J. Peabody, and M. Menon Robot assisted radical prostatectomy for elderly patients with high risk prostate cancer Urol Oncol 31 2013 193 197
25. G. Jayram, G.J. Decastro, and M.C. Large et al. Robotic radical prostatectomy in patients with high-risk disease: a review of short-term outcomes from a high-volume center J Endourol 25 2011 455 457
26. D. Sagalovich, A. Calaway, A. Srivastava, P. Sooriakumaran, and A.K. Tewari Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes BJU Int 111 2013 85 94
27. B.E. Yuh, N.H. Ruel, R. Mejia, C.M. Wilson, and T.G. Wilson Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer Eur Urol 61 2012 1004 1010
28. Y.C. Ou, C.K. Yang, and J. Wang et al. The trifecta outcome in 300 consecutive cases of robotic-assisted laparoscopic radical prostatectomy according to D'Amico risk criteria Eur J Surg Oncol 39 2013 107 113
29. J.H. Jung, J.W. Seo, and M.S. Lim et al. Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer J Laparoendosc Adv Surg Tech A 22 2012 785 790
30. J.T. Casey, J.J. Meeks, K.A. Greco, S.D. Wu, and R.B. Nadler Outcomes of locally advanced (T3 or greater) prostate cancer in men undergoing robot-assisted laparoscopic prostatectomy J Endourol 23 2009 1519 1522
31. J. Uberoi, D. Brison, N. Patel, I.S. Sawczuk, and R. Munver Robot-assisted laparoscopic radical prostatectomy in patients with prostate cancer with high-risk features: predictors of favorable pathologic outcome J Endourol 24 2010 403 407
32. C.J. Kane, J.C. Presti Jr., C.L. Amling, W.J. Aronson, M.K. Terris, S.J. Freedland SEARCH Database Study Group Changing nature of high risk patients undergoing radical prostatectomy J Urol 177 2007 113 117
33. C.T. Nguyen, A.M. Reuther, A.J. Stephenson, E.A. Klein, and J.S. Jones The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival J Urol 181 2009 75 80
34. A. Tewari, G. Divine, and P. Chang et al. Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy - a propensity scoring approach [published correction appears in J Urol 2007;177:1958] J Urol 177 2007 911 915
35. M.J. Zelefsky, J.A. Eastham, and A.M. Cronin et al. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix J Clin Oncol 28 2010 1508 1513
36. M.R. Cooperberg, A.J. Vickers, J.M. Broering, and P.R. Carroll Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer [published correction appears in Cancer 2011;117:2825] Cancer 116 2010 5226 5234
37. H. Van Poppel, and S. Joniau An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer Eur Urol 53 2008 253 259
38. C.O. Wambi, S.A. Siddiqui, L.S. Krane, P.K. Agarwal, H.J. Stricker, and J.O. Peabody Early oncological outcomes of robot-assisted radical prostatectomy for high-grade prostate cancer BJU Int 106 2010 1739 1745
39. P. Bader, F.C. Burkhard, R. Markwalder, and U.E. Studer Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169 2003 849 854
40. J.L. Silberstein, A.J. Vickers, and N.E. Power et al. Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures J Endourol 26 2012 748 753
41. F. Abdollah, M. Sun, and R. Thuret et al. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer Int J Urol 19 2012 645 651
42. F.C. Burkhard, and U.E. Studer The role of lymphadenectomy in high risk prostate cancer World J Urol 26 2008 231 236
43. V. Pagliarulo, D. Hawes, and F.H. Brands et al. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer J Clin Oncol 24 2006 2735 2742
44. J. Ji, H. Yuan, L. Wang, and J. Hou Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study J Surg Res 178 2012 779 784
45. Yuh BE, Ruel NH, Mejia R, Novara G, Wilson TG. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer. BJU Int. In press. http://dx.doi.org/10.1111/j.1464-410X.2012.11788.x.
46. V. Pagliarulo, S. Bracarda, and M.A. Eisenberger et al. Contemporary role of androgen deprivation therapy for prostate cancer Eur Urol 61 2012 11 25
47. R. Miocinovic, R.K. Berglund, and A.J. Stephenson et al. Avoiding androgen deprivation therapy in men with high-risk prostate cancer: the role of radical prostatectomy as initial treatment Urology 77 2011 946 950
48. S.A. Boorjian, R.J. Karnes, and R. Viterbo et al. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer Cancer 117 2011 2883 2891
49. J.S. Brajtbord, H.J. Lavery, F. Nabizada-Pace, P. Senaratne, and D.B. Samadi Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer BJU Int 107 2011 1419 1424
50. A. Briganti, M. Spahn, and S. Joniau et al. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis Eur Urol 63 2013 693 701